[Therapeutic and pharmacological effects of second-generation antipsychotics on drug-resistant bipolar depression].
Kuroki
Toshihide
T
Kaminiwa
Shigenobu
S
Haeno
Makoto
M
Kohara
Kimio
K
Ninomiya
Hideaki
H
D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000494:pharmacology / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000494:pharmacology / Q000627:therapeutic use; D001007:Anxiety; D001569:Benzodiazepines / Q000494:pharmacology / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000523:psychology; D003071:Cognition; D003987:Dibenzothiazepines / Q000494:pharmacology / Q000627:therapeutic use; D015195:Drug Design; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D000077152:Olanzapine; D000069348:Quetiapine Fumarate; D018967:Risperidone / Q000494:pharmacology / Q000627:therapeutic use
D018687:Antidepressive Agents, Second-Generation; D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D001569:Benzodiazepines; D000069348:Quetiapine Fumarate; D018967:Risperidone; D000077152:Olanzapine